127 related articles for article (PubMed ID: 23320435)
1. Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
Donohoe G; Walters J; Hargreaves A; Rose EJ; Morris DW; Fahey C; Bellini S; Cummins E; Giegling I; Hartmann AM; Möller HJ; Muglia P; Owen MJ; Gill M; O'Donovan MC; Tropea D; Rujescu D; Corvin A
Genes Brain Behav; 2013 Mar; 12(2):203-9. PubMed ID: 23320435
[TBL] [Abstract][Full Text] [Related]
2. The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males.
Koiliari E; Roussos P; Pasparakis E; Lencz T; Malhotra A; Siever LJ; Giakoumaki SG; Bitsios P
Schizophr Res; 2014 Apr; 154(1-3):42-7. PubMed ID: 24630139
[TBL] [Abstract][Full Text] [Related]
3. Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
Rose EJ; Morris DW; Hargreaves A; Fahey C; Greene C; Garavan H; Gill M; Corvin A; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):530-7. PubMed ID: 23839771
[TBL] [Abstract][Full Text] [Related]
4. No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population.
Liu Y; Cheng Z; Wang J; Jin C; Yuan J; Wang G; Zhang F; Zhao X
BMC Psychiatry; 2016 Jul; 16():206. PubMed ID: 27377754
[TBL] [Abstract][Full Text] [Related]
5. A genetic association study of CSMD1 and CSMD2 with cognitive function.
Athanasiu L; Giddaluru S; Fernandes C; Christoforou A; Reinvang I; Lundervold AJ; Nilsson LG; Kauppi K; Adolfsson R; Eriksson E; Sundet K; Djurovic S; Espeseth T; Nyberg L; Steen VM; Andreassen OA; Le Hellard S
Brain Behav Immun; 2017 Mar; 61():209-216. PubMed ID: 27890662
[TBL] [Abstract][Full Text] [Related]
6. Replicated association between the European GWAS locus rs10503253 at CSMD1 and schizophrenia in Asian population.
Liu W; Liu F; Xu X; Bai Y
Neurosci Lett; 2017 Apr; 647():122-128. PubMed ID: 28344127
[TBL] [Abstract][Full Text] [Related]
7. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.
Donohoe G; Walters J; Morris DW; Quinn EM; Judge R; Norton N; Giegling I; Hartmann AM; Möller HJ; Muglia P; Williams H; Moskvina V; Peel R; O'Donoghue T; Owen MJ; O'Donovan MC; Gill M; Rujescu D; Corvin A
Arch Gen Psychiatry; 2009 Oct; 66(10):1045-54. PubMed ID: 19805695
[TBL] [Abstract][Full Text] [Related]
8. Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.
Drgonova J; Walther D; Singhal S; Johnson K; Kessler B; Troncoso J; Uhl GR
PLoS One; 2015; 10(7):e0120908. PubMed ID: 26171607
[TBL] [Abstract][Full Text] [Related]
9. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.
Walters JT; Rujescu D; Franke B; Giegling I; Vásquez AA; Hargreaves A; Russo G; Morris DW; Hoogman M; Da Costa A; Moskvina V; Fernández G; Gill M; Corvin A; O'Donovan MC; Donohoe G; Owen MJ
Am J Psychiatry; 2013 Aug; 170(8):877-85. PubMed ID: 23903335
[TBL] [Abstract][Full Text] [Related]
10. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.
Walters JT; Corvin A; Owen MJ; Williams H; Dragovic M; Quinn EM; Judge R; Smith DJ; Norton N; Giegling I; Hartmann AM; Möller HJ; Muglia P; Moskvina V; Dwyer S; O'Donoghue T; Morar B; Cooper M; Chandler D; Jablensky A; Gill M; Kaladjieva L; Morris DW; O'Donovan MC; Rujescu D; Donohoe G
Arch Gen Psychiatry; 2010 Jul; 67(7):692-700. PubMed ID: 20603450
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.
Rose EJ; Hargreaves A; Morris D; Fahey C; Tropea D; Cummings E; Caltagirone C; Bossù P; Chiapponi C; Piras F; Spalletta G; Gill M; Corvin A; Donohoe G
Br J Psychiatry; 2014 Feb; 204(2):115-21. PubMed ID: 24311551
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.
Steen VM; Nepal C; Ersland KM; Holdhus R; Nævdal M; Ratvik SM; Skrede S; Håvik B
PLoS One; 2013; 8(11):e79501. PubMed ID: 24244513
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients.
Liu Y; Fu X; Tang Z; Li C; Xu Y; Zhang F; Zhou D; Zhu C
BMC Psychiatry; 2019 Apr; 19(1):113. PubMed ID: 30987620
[TBL] [Abstract][Full Text] [Related]
14. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.
Håvik B; Le Hellard S; Rietschel M; Lybæk H; Djurovic S; Mattheisen M; Mühleisen TW; Degenhardt F; Priebe L; Maier W; Breuer R; Schulze TG; Agartz I; Melle I; Hansen T; Bramham CR; Nöthen MM; Stevens B; Werge T; Andreassen OA; Cichon S; Steen VM
Biol Psychiatry; 2011 Jul; 70(1):35-42. PubMed ID: 21439553
[TBL] [Abstract][Full Text] [Related]
15. The one and the many: effects of the cell adhesion molecule pathway on neuropsychological function in psychosis.
Hargreaves A; Anney R; O'Dushlaine C; Nicodemus KK; ; ; Gill M; Corvin A; Morris D; Donohoe G
Psychol Med; 2014 Jul; 44(10):2177-87. PubMed ID: 24284030
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood.
Hatzimanolis A; Bhatnagar P; Moes A; Wang R; Roussos P; Bitsios P; Stefanis CN; Pulver AE; Arking DE; Smyrnis N; Stefanis NC; Avramopoulos D
Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):392-401. PubMed ID: 25963331
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory.
Cosgrove D; Mothersill O; Kendall K; Konte B; Harold D; Giegling I; Hartmann A; Richards A; Mantripragada K; ; Owen MJ; O'Donovan MC; Gill M; Rujescu D; Walters J; Corvin A; Morris DW; Donohoe G
Neuropsychopharmacology; 2017 Dec; 42(13):2612-2622. PubMed ID: 28607492
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.
Hatzimanolis A; Foteli S; Stefanatou P; Ntigrintaki AA; Ralli I; Kollias K; Nikolaou C; Gazouli M; Stefanis NC
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1219-1228. PubMed ID: 35532796
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.
Green MJ; Cairns MJ; Wu J; Dragovic M; Jablensky A; Tooney PA; Scott RJ; Carr VJ;
Mol Psychiatry; 2013 Jul; 18(7):774-80. PubMed ID: 22733126
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder.
Harvey PD; Sun N; Bigdeli TB; Fanous AH; Aslan M; Malhotra AK; Lu Q; Hu Y; Li B; Chen Q; Mane S; Miller P; Rajeevan N; Sayward F; Cheung KH; Li Y; Greenwood TA; Gur RE; Braff DL; ; Brophy M; Pyarajan S; O'Leary TJ; Gleason T; Przygodszki R; Muralidhar S; Gaziano JM; Concato J; Zhao H; Siever LJ
Am J Med Genet B Neuropsychiatr Genet; 2020 Apr; 183(3):181-194. PubMed ID: 31872970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
